Multiple sclerosis (MS) is diagnosed through a combination of MRI scans, neurological exams, and sometimes spinal fluid analysis, all guided by a formal set of rules called the McDonald criteria. There is no single test that confirms MS on its own. Instead, doctors piece together evidence showing that the immune system has attacked the brain or spinal cord in more than one location and at more than one point in time.
The Core Principle: Damage in Multiple Places and Times
The hallmark of MS is that the immune system strips away the protective coating on nerve fibers in the central nervous system. For a diagnosis, doctors need to prove two things. First, that this damage has occurred in at least two separate areas of the brain or spinal cord, a concept called dissemination in space. Second, that it happened on at least two separate occasions, known as dissemination in time. These two requirements exist to distinguish MS from a one-time inflammatory event or from other conditions that can look similar on a scan.
The McDonald criteria, most recently updated in 2024, spell out exactly how these requirements can be met using MRI findings, clinical symptoms, and lab results. When both criteria are satisfied and other explanations have been ruled out, a doctor can make a definitive MS diagnosis.
What MRI Reveals
MRI is the most important tool in diagnosing MS. It can detect lesions (areas of damage) in the brain and spinal cord that are too small to cause noticeable symptoms yet still count toward a diagnosis. For dissemination in space, doctors look for at least one lesion in at least two of five characteristic locations: near the brain’s ventricles (fluid-filled chambers), in the outer layer of the brain (cortical or juxtacortical areas), in the brainstem or cerebellum (infratentorial), in the spinal cord, or, as of the 2024 criteria update, in the optic nerve. Each lesion must measure at least 3 mm in one direction to count.
Spinal cord imaging adds valuable information, especially when brain scans are inconclusive. About 40% of spinal cord lesions appear in the mid-to-lower regions, so imaging the entire cord with at least two different MRI sequences improves detection. Dissemination in time can be demonstrated on a single MRI if some lesions enhance with a contrast dye (indicating they’re new and actively inflamed) while others don’t (indicating older, healed damage). If that pattern isn’t present, a follow-up MRI showing a new lesion at a later date also satisfies the requirement.
Newer MRI Markers
The 2024 McDonald criteria now recognize two additional MRI features that can strengthen a diagnosis. The central vein sign refers to a tiny vein running through the middle of a lesion, a pattern that’s common in MS but rare in lookalike conditions. Paramagnetic rim lesions are lesions with a distinctive rim of immune cells visible on certain MRI sequences, suggesting ongoing, smoldering inflammation. These markers aren’t required for diagnosis, but when available, they add confidence.
Spinal Fluid Testing
A lumbar puncture (spinal tap) collects cerebrospinal fluid to look for signs of immune activity in the central nervous system. The most well-known finding is oligoclonal bands, which are patterns of antibodies that appear in the spinal fluid but not in the blood. Their presence indicates the immune system is active inside the nervous system.
About 68 to 85% of people with MS test positive for oligoclonal bands, depending on when during the disease they’re tested. People tested earlier in the disease course tend to have higher positivity rates. Under the current criteria, a positive oligoclonal band result can substitute for dissemination in time. This means that if your MRI shows lesions in multiple locations and your spinal fluid contains oligoclonal bands, you can receive a diagnosis without waiting for a second clinical episode or follow-up scan.
The 2024 criteria also mention kappa free light chains in spinal fluid as another supportive marker. These are a type of antibody fragment that, when elevated, points toward immune activity consistent with MS.
The Neurological Exam
Before any imaging or lab work, diagnosis usually starts with a thorough neurological exam. Your doctor will test your reflexes, eye movements, coordination, balance, sensation, and muscle strength. They’re looking for subtle signs of nerve damage that might not be immediately obvious, like a slight delay in one pupil’s response to light or mild weakness on one side of the body.
In some cases, a visual evoked potential test is used. You watch a checkerboard pattern on a screen while electrodes on your scalp measure how quickly your brain processes the visual signal. In a healthy eye, the brain registers the signal in about 100 milliseconds. A significant delay suggests the optic nerve has been damaged by demyelination, even if you haven’t noticed vision problems. This test is most useful when optic nerve involvement is suspected but not confirmed by MRI.
Clinically Isolated Syndrome
Many people’s path to an MS diagnosis begins with a clinically isolated syndrome (CIS), a single episode of neurological symptoms lasting at least 24 hours. Common first episodes include optic neuritis (blurred or lost vision in one eye), numbness or tingling in the limbs, or difficulty with balance. At this stage, you don’t yet meet the criteria for MS because only one event has occurred.
The risk of progressing from CIS to a full MS diagnosis depends largely on what the MRI shows. An Italian study found that 57% of people with CIS met MS criteria within two years, 67% within three years, and 75% within four years. If your MRI at the time of CIS already shows multiple lesions in characteristic locations and your spinal fluid is positive for oligoclonal bands, your doctor may be able to diagnose MS right away under the current criteria rather than making you wait for a second attack.
Radiologically Isolated Syndrome
Sometimes MRI scans done for unrelated reasons (a head injury, migraines) reveal lesions that look exactly like MS, even though the person has never experienced neurological symptoms. This is called radiologically isolated syndrome (RIS). Under the 2024 criteria, some people with RIS can now be diagnosed with early MS if their scans show characteristic lesions and their spinal fluid contains oligoclonal bands, even without a clinical attack. This is a significant shift, because previous criteria required at least one symptomatic episode.
People with RIS who don’t meet the threshold for an MS diagnosis are typically monitored with annual MRI scans for up to 10 years, watching for new lesion activity that might change the picture.
Ruling Out Other Conditions
No part of the diagnostic process is more important than making sure the symptoms and MRI findings aren’t caused by something else. Dozens of conditions can mimic MS, including lupus, sarcoidosis, vitamin B12 deficiency, Lyme disease, and certain vascular diseases that create white matter lesions on MRI. Some infections, including HIV and syphilis, can also produce similar-looking brain lesions.
To rule these out, doctors order a panel of blood tests. The specifics vary by situation, but common ones check for markers of autoimmune disease (such as antinuclear antibodies), vitamin B12 and folic acid levels, inflammatory markers, and antibodies against infections like Lyme disease. In older patients especially, small-vessel disease from high blood pressure or diabetes can create spots on MRI that look superficially like MS lesions, making the newer MRI markers like the central vein sign particularly helpful for telling them apart.
What Diagnosis Typically Looks Like in Practice
For most people, the diagnostic journey starts with a noticeable symptom: sudden vision loss in one eye, unexplained numbness, or difficulty walking. A primary care doctor refers you to a neurologist, who performs a clinical exam and orders a brain and spinal cord MRI. If that MRI shows lesions in characteristic locations, the neurologist may order a lumbar puncture and blood work to confirm immune activity and exclude other causes.
In straightforward cases where the MRI clearly shows dissemination in space and time, diagnosis can happen within weeks. In more ambiguous cases, particularly when there’s only one lesion or the clinical picture is unclear, you may enter a monitoring phase with repeat MRIs every few months. The 2024 criteria revisions have generally shortened the time to diagnosis by expanding what counts as evidence, including the addition of the optic nerve as a fifth diagnostic location and the acceptance of new biomarkers. Still, some people wait months or even years for a definitive answer, especially when initial findings are borderline.